EnsoData names new chief commercial officer
By HME News Staff
Updated 12:28 PM CDT, Thu May 22, 2025
MADISON, Wis. – EnsoData has named Bobby Cockrill as chief commercial officer to oversee strategy and execution of sales and marketing functions and continue accelerating EnsoSleep PPG, EnsoSleep, RPM and EnsoTherapy adoption across North America. Previously, Cockrill worked at Bardy Diagnostics (BDx), which offered a patch-based cardiac monitoring solution. There, he grew a lean sales team into a force of 60-plus, leading to 100x revenue growth over his eight years. “Bobby’s extensive experience in cardiac monitoring positions him very well to scale EnsoData’s analogous offerings in sleep,” said Justin Mortara, Ph.D., CEO and president. “We anticipate significant expansion of the commercial team under Bobby’s leadership and are excited for this next chapter of growth.” Cockrill said he looks forward to helping scale an organization with such a solid foundation of proven AI solutions. “We’re now entering a high-growth phase, and I’m especially energized to expand our reach and grow a world-class team of healthcare sales executives to drive the next chapter," he said.
Comments